SLC16A10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.389790E-01
Normal-vs-Stage2
5.405600E-01
Normal-vs-Stage3
3.037400E-01
Normal-vs-Stage4
7.312400E-01
Stage1-vs-Stage2
1.66642999999134E-05
Stage1-vs-Stage3
1.525620E-02
Stage1-vs-Stage4
1.003820E-01
Stage2-vs-Stage3
9.082800E-01
Stage2-vs-Stage4
6.565600E-01
Stage3-vs-Stage4
4.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.713400E-01
Normal-vs-AfricanAmerican
4.049600E-01
Normal-vs-Asian
7.103200E-01
Caucasian-vs-AfricanAmerican
5.524200E-01
Caucasian-vs-Asian
1.897810E-02
AfricanAmerican-vs-Asian
3.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.364000E-01
Normal-vs-Female
5.378000E-01
Male-vs-Female
4.631800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.714000E-01
Normal-vs-Age(41-60Yrs)
4.534800E-01
Normal-vs-Age(61-80Yrs)
5.875000E-01
Normal-vs-Age(81-100Yrs)
7.524200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.651000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.107200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.599200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.835600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.886800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.163200E-01
Normal-vs-Daily Drinker
8.021800E-01
Normal-vs-Weekly Drinker
3.759800E-01
Normal-vs-Occasional Drinker
6.189000E-01
Normal-vs-Social Drinker
4.920000E-01
Non Drinker-vs-Daily Drinker
8.678600E-01
Non Drinker-vs-Weekly Drinker
5.998600E-01
Non Drinker-vs-Occasional Drinker
6.468400E-01
Non Drinker-vs-Social Drinker
5.518600E-01
Daily Drinker-vs-Weekly Drinker
9.211800E-01
Daily Drinker-vs-Occasional Drinker
8.908400E-01
Daily Drinker-vs-Social Drinker
8.766400E-01
Weekly Drinker-vs-Occasional Drinker
9.312200E-01
Weekly Drinker-vs-Social Drinker
9.162400E-01
Occasional Drinker-vs-Social Drinker
9.981600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.376200E-01
Normal-vs-Grade 2
6.016000E-01
Normal-vs-Grade 3
6.245000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.731600E-01
Grade 1-vs-Grade 3
4.364800E-01
Grade 1-vs-Grade 4
6.376200E-01
Grade 2-vs-Grade 3
9.399200E-01
Grade 2-vs-Grade 4
6.016000E-01
Grade 3-vs-Grade 4
6.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.137200E-01
Normal-vs-NonDiabetic
6.586000E-01
Diabetic-vs-NonDiabetic
1.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.338200E-01
Normal-vs-NoPancreatitis
6.100200E-01
Pancreatitis-vs-NoPancreatitis
9.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.688200E-01
Normal-vs-N1
5.002800E-01
N0-vs-N1
4.443800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.069600E-01
Normal-vs-TP53-NonMutant
5.181800E-01
TP53-Mutant-vs-TP53-NonMutant
8.652400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
